NeuroPace (NPCE) Gross Margin (2020 - 2026)

NeuroPace's Gross Margin history runs 7 years deep, the most recent figure standing at 81.78% for Q1 2026.

• On a quarterly basis, Gross Margin rose 479.0% year-over-year to 81.78% in Q1 2026; TTM through Mar 2026 was 78.29%, a 347.0% increase from a year earlier, with the FY2025 full-year figure at 77.23%, up 329.0% from the prior year.
• Gross Margin advanced to 81.78% in Q1 2026 per NPCE's latest filing, from 77.4% in the prior quarter.
• Across five years, Gross Margin topped out at 81.78% in Q1 2026 and bottomed at 68.83% in Q4 2022.
• The 5-year median for Gross Margin is 73.62% (2024), against an average of 74.48%.
• Across the five-year window, Gross Margin plunged 461 bps in 2022 and soared 637 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 68.83% in 2022, then gained by 9 bps to 75.2% in 2023, then gained by 0 bps to 75.41% in 2024, then gained by 3 bps to 77.4% in 2025, then grew by 6 bps to 81.78% in 2026.
• Per Business Quant, the three latest NPCE Gross Margin figures stand at 81.78% (Q1 2026), 77.4% (Q4 2025), and 77.39% (Q3 2025).